A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer.
暂无分享,去创建一个
J. Hainsworth | H. Burris | D. Yardley | N. Peacock | D. Spigel | F. Greco | E. Vazquez | D. Molthrop | M. Kommor